Can a Hair-Growing drug help breast reconstruction heal better?

NCT ID NCT07264790

First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study tests whether applying minoxidil (a hair growth drug) to the breasts for two weeks before surgery can improve blood flow and tissue survival in women undergoing preventive mastectomy with reconstruction. Twenty-five women at high genetic risk for breast cancer will have one breast treated with minoxidil and the other with a placebo, without knowing which is which. The goal is to see if this simple approach is feasible and might reduce surgical complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST RECONSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke Health

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

minoxidil

What this could lead to

If it works, this could point toward a simple way to improve healing and reduce complications in breast reconstruction surgery.

What could go wrong

This is a very early, small phase 1 trial focused on feasibility, not effectiveness. The results may not lead to a proven treatment.

Conditions

The condition(s) this trial relates to.

inherited disease susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.